ARH Activators
ARH activators refers to a distinct class of chemical compounds that exert their influence on a molecular pathway associated with lipid metabolism. ARH, or autosomal recessive hypercholesterolemia protein, plays a crucial role in regulating the cellular uptake of low-density lipoprotein (LDL) cholesterol. The activation of ARH is vital for the proper functioning of this pathway, as it facilitates the internalization of LDL particles into cells, a process essential for maintaining cholesterol homeostasis. ARH activators, therefore, are compounds that modulate the activity of the ARH protein, impacting the intricate machinery governing lipid handling within cells.
Chemically, ARH activators can exhibit diverse structural characteristics, with certain compounds displaying a propensity for interacting with specific binding sites on the ARH protein. This interaction may trigger conformational changes or alter the protein's affinity for other molecules, ultimately influencing the efficiency of LDL cholesterol uptake. The intricate interplay between ARH activators and the ARH protein underscores the complexity of cellular mechanisms regulating cholesterol levels. Research in this area is instrumental not only for expanding our understanding of lipid metabolism but also for potentially uncovering new avenues for the modulation of cellular cholesterol dynamics.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Inhibits clathrin-mediated endocytosis, potentially activating the internalization of LDL and the activation of ARH. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Acts as a dynamin inhibitor, modulating endocytosis processes that could activate cellular functions involving ARH. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Inhibits HMG-CoA reductase, indirectly activating LDL receptor expression and potential activation of ARH. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Inhibits cholesterol absorption in the small intestine, indirectly activating LDL receptor function and ARH activation. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates peroxisome proliferator-activated receptor alpha (PPARα), potentially activating lipid metabolism and ARH. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits phosphoinositide 3-kinase (PI3-Kinase), potentially activating signaling pathways associated with ARH activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum protein kinase inhibitor, affecting various kinases and potentially activating pathways related to ARH. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Inhibits Protein Kinase C (PKC), potentially activating cellular signaling pathways involving ARH. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport within the Golgi apparatus, potentially activating the intracellular trafficking of proteins, including ARH. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA), potentially activating cellular processes associated with ARH activation. | ||||||